Abvc Biopharma (ABVC) Gains (Losses) on Sale of Assets & Investments (2018 - 2026)
Abvc Biopharma (ABVC) posted Gains (Losses) on Sale of Assets & Investments of -$6,816 for Q3 2026, compared with -$54,235 a year earlier.
Powered by 
Analysis
Abvc Biopharma (ABVC) Gains (Losses) on Sale of Assets & Investments (2018 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Gains (Losses) on Sale of Assets & Investments at Abvc Biopharma was -$105,728; for FY2025, it was -$192,759.
- In prior years, Abvc Biopharma's Gains (Losses) on Sale of Assets & Investments was -$339,171 in FY2024, -$221,888 in FY2023 and -$7,446 in FY2022.
- The Q3 2026 figure stands as the highest quarterly Gains (Losses) on Sale of Assets & Investments since Q4 2020.
- According to Business Quant data, Gains (Losses) on Sale of Assets & Investments for the three prior quarters was -$24,766 (Q2 2026), -$31,416 (Q1 2026) and -$42,730 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | - |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | -6,816.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -6,816.00 |
| Jun 30, 2026 | -24,766.00 |
| Mar 31, 2026 | -31,416.00 |
| Dec 31, 2025 | -42,730.00 |
| Sep 30, 2025 | -54,235.00 |
| Jun 30, 2025 | -44,917.00 |
| Mar 31, 2025 | -50,877.00 |
| Dec 31, 2024 | -192,229.00 |
| Sep 30, 2024 | -67,885.00 |
| Jun 30, 2024 | -79,057.00 |
| Dec 31, 2020 | -2,317.00 |
| Sep 30, 2020 | 665.00 |
| Jun 30, 2020 | -38,937.00 |
| Dec 31, 2019 | -27,973.00 |
| Sep 30, 2019 | -64,689.00 |
| Dec 31, 2018 | 288,062.00 |
| Sep 30, 2018 | -201,590.00 |
| Jun 30, 2018 | -85,923.00 |
API Access
Abvc Biopharma Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();